{
  "actions": [
    {
      "acted_at": "2018-12-20", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-12-20", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-12-20", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hconres146-115", 
  "bill_type": "hconres", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "115", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-12-20", 
  "number": "146", 
  "official_title": "Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "B001248", 
    "district": "26", 
    "name": "Burgess, Michael C.", 
    "state": "TX", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-12-20", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2018-12-20T05:00:00Z", 
    "text": "Expresses the sense of Congress that:\n\n the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; and the proposed rule by the CMS published in the Federal Register on October 18, 2018, when finalized, shall be codified without change."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T15:52:57Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hconres/BILLSTATUS-115hconres146.xml"
}